Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an essential electrolyte used to prevent or treat hypokalemia. It is available in oral and intravenous formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
## Adult Dosing
* **Oral:**
* Prevention: 20 mEq (1.5 g) per day in 1-2 divided doses.
* Treatment: 40-100 mEq (3-7.5 g) per day in 2-4 divided doses. Higher doses may be required in severe cases.
* Maximum single dose (immediate-release): Generally 20 mEq.
* Maximum daily dose: Not strictly defined, but typically monitored closely and guided by serum potassium levels and patient tolerance.
* **Intravenous (IV):**
* Administer only after careful assessment of serum potassium, ECG, and urine output.
* Mild to moderate hypokalemia (serum K 2.5-3.5 mEq/L): 10-20 mEq per dose, infused over 1-2 hours.
* Severe hypokalemia (serum K < 2.5 mEq/L) or ECG abnormalities: Up to 40 mEq per dose, infused over 2-3 hours.
* Maximum infusion rate: 10-20 mEq/hour in peripheral lines; up to 40 mEq/hour in central lines with continuous ECG monitoring.
* Maximum daily dose: 200-400 mEq, with close monitoring.
## Pediatric Dosing
* **Oral:**
* Prevention: 1-2 mEq/kg/day in 1-2 divided doses, not to exceed 10 mEq/day.
* Treatment: 2-5 mEq/kg/day in 2-4 divided doses, not to exceed 40 mEq/day.
* **Intravenous (IV):**
* Dosing is highly individualized based on serum potassium, age, and clinical status.
* Generally, 0.5-1 mEq/kg per dose infused over 1-3 hours.
* Max daily dose: 3 mEq/kg/day or 40 mEq/day, whichever is less, with continuous ECG monitoring.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Reduce dose and monitor potassium closely due to risk of hyperkalemia.
## Contraindications
* Hyperkalemia.
* Conditions causing elevated potassium levels (e.g., severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue injury).
* Anuria, oliguria, or renal failure with azotemia.
* Certain types of heart block.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal pain.
* **Serious:**
* Hyperkalemia (potentially life-threatening): Arrhythmias, muscle weakness, paresthesias, paralysis.
* Gastrointestinal: Bleeding, ulceration, perforation (especially with oral formulations).
* Cardiac: Cardiac arrest, hypotension (with rapid IV infusion).
* Extravasation/phlebitis (with IV administration).
## Key Drug Interactions
* **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **NSAIDs:** May reduce the efficacy of potassium supplementation and increase the risk of hyperkalemia.
* **Digoxin:** Hyperkalemia can antagonize the effects of digoxin; hypokalemia can potentiate digoxin toxicity.
* **Salt substitutes:** Often contain potassium chloride, increasing the risk of hyperkalemia when used concurrently.
## Monitoring
* Serum potassium levels (frequently, especially with IV administration and dose adjustments).
* Renal function (BUN, creatinine).
* ECG (especially with IV administration or suspected hyperkalemia).
* Signs and symptoms of hypokalemia and hyperkalemia.
* Fluid balance.
## Clinical Pearls
* Oral potassium chloride, especially sustained-release formulations, should be taken with food or milk to minimize gastrointestinal upset.
* Dilute IV potassium chloride appropriately. Never administer as a bolus.
* Always ensure adequate urine output before administering IV potassium.
* Hypokalemia can be exacerbated by diuretics, corticosteroids, vomiting, and diarrhea.
* Consider the total daily potassium intake from all sources, including diet and other medications.
***
*This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*
